8-K
filed August 22, 2024, 7:59 PM ET
CIK 0000876378
M&A
confidence high
sentiment neutral
materiality 0.75
ASENSUS SURGICAL, INC.: M&A transaction — KARL STORZ completes acquisition of Asensus Surgical for $0.35 per share in cash
ASENSUS SURGICAL, INC.
- Merger closed Aug 22, 2024; stockholders received $0.35/share in cash for each share.
- Common stock delisted from NYSE American same day; Form 25 filed with SEC.
- All prior directors resigned; Sonal Matai and Nadim Abi Malhab appointed as directors.
- Warrant holders (2023 and Series D) have 30-day option to require cash purchase at Black-Scholes value.
- Asensus becomes a KARL STORZ subsidiary; CEO Anthony Fernando remains; LUNA robot development continues.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Nadim Abi Malhab was appointed as Director at ASENSUS SURGICAL, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
Sonal Matai and Nadim Abi Malhab, the directors of Merger Sub immediately prior to the Effective Time, became directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
David Milne resigned as Director at ASENSUS SURGICAL, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Anthony Fernando, David Milne, Andrea Biffi, Kevin Hobert, Elizabeth Kwo, Richard Pfenniger and William Starling, Jr., the members of the Board of Directors of the Company (the “Board”), holding these positions immediately prior to the effective time resigned from the Board and from all Board committees on which these directors served.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Sonal Matai was appointed as Director at ASENSUS SURGICAL, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
Sonal Matai and Nadim Abi Malhab, the directors of Merger Sub immediately prior to the Effective Time, became directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Richard Pfenniger resigned as Director at ASENSUS SURGICAL, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Anthony Fernando, David Milne, Andrea Biffi, Kevin Hobert, Elizabeth Kwo, Richard Pfenniger and William Starling, Jr., the members of the Board of Directors of the Company (the “Board”), holding these positions immediately prior to the effective time resigned from the Board and from all Board committees on which these directors served.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
William Starling, Jr. resigned as Director at ASENSUS SURGICAL, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Anthony Fernando, David Milne, Andrea Biffi, Kevin Hobert, Elizabeth Kwo, Richard Pfenniger and William Starling, Jr., the members of the Board of Directors of the Company (the “Board”), holding these positions immediately prior to the effective time resigned from the Board and from all Board committees on which these directors served.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Elizabeth Kwo resigned as Director at ASENSUS SURGICAL, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Anthony Fernando, David Milne, Andrea Biffi, Kevin Hobert, Elizabeth Kwo, Richard Pfenniger and William Starling, Jr., the members of the Board of Directors of the Company (the “Board”), holding these positions immediately prior to the effective time resigned from the Board and from all Board committees on which these directors served.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Kevin Hobert resigned as Director at ASENSUS SURGICAL, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Anthony Fernando, David Milne, Andrea Biffi, Kevin Hobert, Elizabeth Kwo, Richard Pfenniger and William Starling, Jr., the members of the Board of Directors of the Company (the “Board”), holding these positions immediately prior to the effective time resigned from the Board and from all Board committees on which these directors served.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Andrea Biffi resigned as Director at ASENSUS SURGICAL, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Anthony Fernando, David Milne, Andrea Biffi, Kevin Hobert, Elizabeth Kwo, Richard Pfenniger and William Starling, Jr., the members of the Board of Directors of the Company (the “Board”), holding these positions immediately prior to the effective time resigned from the Board and from all Board committees on which these directors served.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Anthony Fernando resigned as Director at ASENSUS SURGICAL, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Anthony Fernando, David Milne, Andrea Biffi, Kevin Hobert, Elizabeth Kwo, Richard Pfenniger and William Starling, Jr., the members of the Board of Directors of the Company (the “Board”), holding these positions immediately prior to the effective time resigned from the Board and from all Board committees on which these directors served.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
ASENSUS SURGICAL, INC. underwent a change of control involving KARL STORZ Endoscopy-America, Inc. for $0.35 per share in cash (closed 2024-08-22).
- Action
- change of control
- Counterparty
- KARL STORZ Endoscopy-America, Inc.
- Consideration
- $0.35 per share in cash
- Closing
- 2024-08-22
Exact text from the filing
Time”) as provided in the Merger Agreement: (i) each share of common stock of the Company (the “Common Stock”) then outstanding was converted into the right to receive $0.35 in cash, without interest (the “Merger Consideration”), other than those shares owned by Parent or Merger Sub or the Company (which were cancelled without any consideration); (ii)
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.